Celltrion
068270.KS
$180.32
Share price
-1.89%
Change (1 day)
-12.17%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - P/B ratio
P/B ratio as of April 2025 : 2.05
According to Celltrion
's latest financial reports the company has a price-to-book ratio of 9.51385.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Celltrion - P/B ratio (from 2007 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 2.20 | -12.9% |
| 2023-12-31 | 2.53 | -52.72% |
| 2022-12-31 | 5.35 | -21.48% |
| 2021-12-31 | 6.81 | -52.34% |
| 2020-12-31 | 14.3 | 78.33% |
| 2019-12-31 | 8.01 | -24.98% |
| 2018-12-31 | 10.7 | -6.16% |
| 2017-12-31 | 11.4 | 79.03% |
| 2016-12-31 | 6.36 | 13.97% |
| 2015-12-31 | 5.58 | 89.56% |
| 2014-12-31 | 2.94 | -14.92% |
| 2013-12-31 | 3.46 | -19.46% |
| 2012-12-31 | 4.30 | -10.79% |
| 2011-12-31 | 4.81 | -3.36% |
| 2010-12-31 | 4.98 | -6.24% |
| 2009-12-31 | 5.31 | 16.53% |
| 2008-12-31 | 4.56 | 580.72% |
| 2007-12-31 | 0.6699 |